前幾個月有研究表明那個藥在高危人群中的有效率不到三層,對其它人群無效。早就滖下神壇了
Study Shows Nirmatrelvir–Ritonavir No More Effective Than Placebo for COVID-19 Symptom Relief
Paxlovid COVID Treatment Is Most Beneficial for Unvaccinated People with Risk Factors. Others May Not Need It